NORTHERN TRUST CORP - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,947,691
-8.0%
297,695
+3.5%
0.00%0.0%
Q2 2023$5,377,242
+2.3%
287,553
+0.3%
0.00%0.0%
Q1 2023$5,258,633
+5.7%
286,574
+14.1%
0.00%0.0%
Q4 2022$4,973,582
-16.8%
251,191
+1.1%
0.00%0.0%
Q3 2022$5,979,000
+33.5%
248,496
+1.2%
0.00%0.0%
Q2 2022$4,480,000
-3.9%
245,471
+15.8%
0.00%0.0%
Q1 2022$4,662,000
-40.9%
212,029
-1.2%
0.00%0.0%
Q4 2021$7,885,000
+16.9%
214,696
-1.2%
0.00%0.0%
Q3 2021$6,745,000
+14.2%
217,198
+17.0%
0.00%0.0%
Q2 2021$5,904,000
+95.0%
185,693
+36.1%
0.00%0.0%
Q1 2021$3,028,000
+1.7%
136,423
-9.5%
0.00%0.0%
Q4 2020$2,978,000
-37.7%
150,793
+1.6%
0.00%0.0%
Q3 2020$4,780,000
+10.5%
148,445
-0.4%
0.00%0.0%
Q2 2020$4,326,000
+513.6%
149,073
+350.2%
0.00%
Q1 2020$705,000
+72.0%
33,110
+122.8%
0.00%
Q4 2019$410,00014,8590.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders